Ovarian Cancer Clinical Trials

Showing 421-440 of 1,169 trials

Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer

NCT05931445

This is a multicenter, open-label, randomized, controlled study to test the hypothesis that ePRO monitoring added to usual care helps prolong OS or maintain and improve HRQoL in patients with unresectable advanced cancers or metastatic/recurrent solid tumors receiving systemic drug therapy.

Breast CancerLung CancerColorectal Cancer+5 more

Comprehensive Support Project for Oncology Research500 participantsStarted Jan 2021

Kobe, Hyōgo, Japan

COMPLETEDNA

The Efficacy of WeChat-based Multidisciplinary Full-course Nutritional Management Program

NCT06379191

As the most malignant type of cancer in the female reproductive system, ovarian cancer (OC) has become the second leading cause of death among Chinese women. Chemotherapy is the main treatment for OC patients, and its numerous adverse effects can easily lead to malnutrition. It is difficult to centrally manage OC patients in the intervals between chemotherapy. The utility of WeChat, an effective and more cost-efficient mobile tool, in chronic disease management has been highlighted.

Ovarian Cancer

Peking Union Medical College Hospital78 participantsStarted Feb 2023

Beijing, Beijing Municipality, China

Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer

The Efficacy of WeChat-based Multidisciplinary Full-course Nutritional Management Program

Related Searches

Long Term Survivors in Ovarian Cancer

Feasibility of Lifestyle Intervention in BRCA1/2 Mutation Carriers

Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis

Study of PF-07263689 in Participants With Selected Advanced Solid Tumors

Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer

Endocrine Disruptors and Life STILe in Breast Cancer Development

Efficacy of Lifestyle Intervention in BRCA1/2 Mutation Carriers

A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer

Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin

PPK Study Based on Quantitative Pharmacology in Patients With Pamipril

Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors

Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC

Radiomics and Machine Learning in the Diagnosis of Ovarian Masses

Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum Chemotherapy

Erdafitinib in Metastatic Steroid-cell Ovarian Cancer

Perioperative Exercise and Nutritional Optimisation Prehabilitation Before Surgery for Patients With Peritoneal Malignancy

Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.

Frailty, Quality Of Life and Early Reversal of Temporary Defunctioning Stoma in Ovarian Cancer